Factors associated with unusually long stays in heart failure hospitalizations in Spain
Keywords:
Insuficiencia cardíaca, Estancias. Grupos relacionados de diagnóstico. Comorbilidades. Gestión. Urgencias.Abstract
Background. Heart failure is a process of high prevalence that causes repeated hospital admissions with increased health care costs. The aim of this article is to describe and characterize the cases with long stays due to this syndrome, identifying associated factors wherever possible. Methods. An historical cohort of all the episodes of people over 45 years with a diagnosis of heart failure admitted in the Spanish Public Health System in the period 1997-2007. Source: 808,229 episodes classified as Diagnosis Related Groups 127 and 544 according to the Minimum Basic Data provided by the Institute for Health Information. We assessed sociodemographic variables (age, gender, region), clinical variables (comorbidities, complications, type of admission and discharge) and management variables (length of stay, type of hospital readmissions). An abnormally prolonged stay (APS) was defined as one exceeding the 90th percentile (14 and 16 days, respectively); we built a logistic regression model to assess their possible associated factors. Results. Eleven point four percent (11.4%) presented abnormally prolonged stays, showing lower mean age and increased number of diagnoses and procedures, readmissions and mortality than the non-abnormally prolonged stay group. Anemia, kidney failure, pulmonary embolism or stroke as well as readmission and scheduled admission were associated with increased likelihood of APS. Conclusion. It is possible to define a comorbidities and sociodemographic profile to assess the likelihood of a prolonged hospital stay, but given the nature of administrative database the model’s discriminative ability is quite discreet.Downloads
References
1. HO K, PINSKY J, KANNEL W, LEVY D. The epidemiology of heart failure: the Frammingham study. J Am Coll Cardiol 1993; 22: 4 Suppl A 6A-13A.
https://doi.org/10.1016/0735-1097(93)90455-A
2. LLOYD D, LARSON M, LEIP E, BEISER A, D'AGOSTINO R, KANNEL W et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 2997-2998.
https://doi.org/10.1161/01.CIR.0000039105.49749.6F
3. MCMURRAY J, STEWART S. Epidemiology, aetiology and prognosis of heart failure. Heart 2000; 83: 596-602.
https://doi.org/10.1136/heart.83.5.596
4. DE LA FUENTE CID R, HERMIDA A, PAZO M, LADO F. Epidemiología de la insuficiencia cardiaca. Porporciones de epidemia. An Med Interna (Madrid) 2007; 24: 500-504.
https://doi.org/10.4321/S0212-71992007001000009
5. BANEGAS J, RODRÍGUEZ ARTALEJO J, GUALLAR P. Situación epidemiológica de la insuficiencia cardiaca en España. Rev Esp Cardiol 2006; 6: 4C-9C.
https://doi.org/10.1157/13092028
6. COTS F, CASTELLS X, GARCÍA A, SANZ M. Relación de los costes directos de la hospitalización con la duración de la estancia. Gac Sanit 1997; 11: 287-295.
https://doi.org/10.1016/S0213-9111(97)71309-8
7. CMBD años 1997-2007. Instituto de Información Sanitaria, Ministerio de Sanidad y Política Social. Madrid 2009.
8. Statistical Package for de Social Sciences (SPSS). En: 15 ed. Chicago: SPSS inc 2006.
9. PEIRÓ S, MENEU DE GUILLERNA R, ROSELLÓ ML, MARTÍNEZ E, PORTELLA E. ¿Qué mide la estancia media de los grupos relacionados de diagnóstico? Med Clin 1994; 103: 413-417.
10. CLARK R, INGLIS S, MCALISTER F, CLELAND J, STEWART S. Telemonitoring or structured telephone support programmes for patients with chronic hear failure: systematic review and meta-analysis. Br Med J 2007; 334: 942-950.
https://doi.org/10.1136/bmj.39156.536968.55
11. GAMBOA F, GÓMEZ CAMACHO E, DE VILLAR E, VEGA J, MAYORAL L, LÓPEZ R. Un nuevo modelo de cuidados médicos para los pacientes multiingresadores. Rev Clin Esp 2002; 202: 187-196.
https://doi.org/10.1016/S0014-2565(02)71025-4
12. JENCKS S, WILLIAMS D, KAY T. Assesing hospital-associated deaths from discharge data. JAMA 1988; 260: 2240-2246.
https://doi.org/10.1001/jama.1988.03410150088036
13. IEZZONI LI. Risk adjustment for Medical Outcomes Studies. En: Grady ML, ed. Medical Effectiveness Research Data Methods. Rockville, MD: Agency for Health Care Policy and Research 1992: 83-97.
14. LIBRERO J, PEIRO S. ¿Previenen enfermedades crónicas la mortalidad de intrahospital? Paradojas y tendencias en información sobre morbosidad de hospital. Gac Sanit 1998; 12: 199-206.
https://doi.org/10.1016/S0213-9111(98)76473-8
15. PEIRÓ S, LIBRERO J, ORDIÑANA R. Perfiles de mortalidad hospitalaria: ¿una herramienta útil para la identificación de potenciales problemas de calidad? Rev Calidad Asistencial 1997; 12: 179-187.
https://doi.org/10.1016/S0213-9111(98)76438-6
16. ALTIMIR S, LUPÓN J, GONZÁLEZ B, PRATS M, PARAJÓN T, URRUTIA A et al. Sex and age differences in fragility in a heart failure population. Eur J Heart Fail 2005; 7: 798-802.
https://doi.org/10.1016/j.ejheart.2004.09.015
17. MEZU U, BOTT SILVERMAN C, HISCH E. Heart failure in women is different than in men: should treatment be different? Clevel Clin J Med 2007; 74: 423-435.
https://doi.org/10.3949/ccjm.74.6.423
18. COWIE MR. Annotated references in epidemiology. Eur J Heart Fail 1999; 1: 101-107.
https://doi.org/10.1016/S1388-9842(98)00008-7
19. RODRÍGUEZ J, BANEGAS J, GUALLAR P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol 2004; 57:163-170.
https://doi.org/10.1016/S0300-8932(04)77080-3
20. CORTINA A, REGUERO J, SEGOVIA E, RODRÍGUEZ LAMBERT J, CORTINA R, ARIAS JC et al. Prevalence of heart failure in Asturias (A Region in the North of Spain). Am J Cardiol 2001; 87: 1417-1419.
https://doi.org/10.1016/S0002-9149(01)01568-5
21. ANGUITA M, CRESPO MG, DE TERESA GALVÁN E, JIMÉNEZ M, ALONSO L, MUÑIZ J. Prevalencia de la insuficiencia cardiaca en la poblacion general española mayor de 45 años. Estudio PRICE. Rev Esp Cardiol 2008; 61: 1041-1049.
https://doi.org/10.1157/13126044
22. JIMÉNEZ MF, GARCIA J, ANGUITA M, MARTÍNEZ A, TORRES F. Investigadores del registro RAIC. Características demográficas de los pacientes ingresados por insuficiencia cardiaca en Andalucía: resultados del estudio RAIC. Rev And Cardiol 2006; 41:107-113.
23. ANGUITA M. Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardiaca controlados en consultas específicas de insuficiencia cardiaca. Resultados del registro BADAPIC. Rev Esp Cardiol 2004; 57: 1159-1169.
https://doi.org/10.1157/13069862
24. OTERO F, GRIGORIAN L, FRANSI L, NÁZARA C, FERNÁNDEZ JM, DEL ALAMO A et al. Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP study. Int J Cardiol 2009; 136: 56-63.
https://doi.org/10.1016/j.ijcard.2008.04.025
25. SETO E. Cost comparison between telemonitoring and usual care of heart failure: a systemactic review. Telemed JE Health 2008; 14: 679-686.
https://doi.org/10.1089/tmj.2007.0114
26. CHAUDHRY S, WANG Y, CONCATO J, GILL T, KRUMHOLZ H. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007; 116: 1549-1554.
https://doi.org/10.1161/CIRCULATIONAHA.107.690768
27. WEINTRAUB NL, COLLINS SP, PANG PS, LEVY PD, ANDERSON AS, ARSLANIAN-ENGOREN A et al. Acute heart failure syndromes: Emergency Department presentation, treatment and disposition: current approaches and future aim. A scientific statement from the American Heart Association. Circulation 2010; doi: 10.1161/CIR.0b013e3181f9a223.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Anales del Sistema Sanitario de Navarra

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.


